Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  HIV Infection

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 65 articles:
HTML format



Single Articles


    September 2022
  1. COLLIE S, Nayager J, Bamford L, Bekker LG, et al
    Effectiveness and Durability of the BNT162b2 Vaccine against Omicron Sublineages in South Africa.
    N Engl J Med. 2022 Sep 14. doi: 10.1056/NEJMc2210093.
    PubMed    


  2. ANDERSON AS, Caubel P, Rusnak JM
    Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
    N Engl J Med. 2022 Sep 7. doi: 10.1056/NEJMc2205944.
    PubMed    


  3. CONRADIE F, Bagdasaryan TR, Borisov S, Howell P, et al
    Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis.
    N Engl J Med. 2022;387:810-823.
    PubMed     Abstract available


  4. PATEL K, Huo Y, Jao J, Powis KM, et al
    Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United States.
    N Engl J Med. 2022;387:799-809.
    PubMed     Abstract available


    August 2022
  5. MARCUS JL, Killelea A, Krakower DS
    HIV Prevention and the 340B Drug Pricing Program. Reply.
    N Engl J Med. 2022;387:576.
    PubMed    


  6. HALL CS
    HIV Prevention and the 340B Drug Pricing Program.
    N Engl J Med. 2022;387:575-576.
    PubMed    


    July 2022
  7. THORNHILL JP, Barkati S, Walmsley S, Rockstroh J, et al
    Monkeypox Virus Infection in Humans across 16 Countries - April-June 2022.
    N Engl J Med. 2022 Jul 21. doi: 10.1056/NEJMoa2207323.
    PubMed     Abstract available


    June 2022
  8. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    PubMed     Abstract available


  9. ALTARAWNEH HN, Chemaitelly H, Ayoub HH, Tang P, et al
    Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMoa2203965.
    PubMed     Abstract available


  10. MARCUS JL, Killelea A, Krakower DS
    Perverse Incentives - HIV Prevention and the 340B Drug Pricing Program.
    N Engl J Med. 2022;386:2064-2066.
    PubMed    


    May 2022
  11. MARRAZZO J
    Lenacapavir for HIV-1 - Potential Promise of a Long-Acting Antiretroviral Drug.
    N Engl J Med. 2022;386:1848-1849.
    PubMed    


  12. SEGAL-MAURER S, DeJesus E, Stellbrink HJ, Castagna A, et al
    Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
    N Engl J Med. 2022;386:1793-1803.
    PubMed     Abstract available


  13. GRAY G, Collie S, Goga A, Garrett N, et al
    Effectiveness of Ad26.COV2.S and BNT162b2 Vaccines against Omicron Variant in South Africa.
    N Engl J Med. 2022 May 4. doi: 10.1056/NEJMc2202061.
    PubMed    


    April 2022
  14. MOORE PL, Baden LR
    Omicron - Decoupling Infection from Severe Disease.
    N Engl J Med. 2022;386:1361-1362.
    PubMed    


    March 2022
  15. JARVIS JN, Lawrence DS, Meya DB, Kagimu E, et al
    Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.
    N Engl J Med. 2022;386:1109-1120.
    PubMed     Abstract available


  16. LUEKING R, Lazarte S
    Malignant Syphilis.
    N Engl J Med. 2022;386:e26.
    PubMed    


  17. OZELO MC, Mahlangu J, Pasi KJ, Giermasz A, et al
    Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A.
    N Engl J Med. 2022;386:1013-1025.
    PubMed     Abstract available


  18. TURKOVA A, Wills GH, Wobudeya E, Chabala C, et al
    Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children.
    N Engl J Med. 2022;386:911-922.
    PubMed     Abstract available


  19. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, AlMukdad S, et al
    Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar.
    N Engl J Med. 2022 Mar 9. doi: 10.1056/NEJMoa2200797.
    PubMed     Abstract available


    February 2022
  20. SILVERMAN RF, Shinder R
    Molluscum Contagiosum.
    N Engl J Med. 2022;386:582.
    PubMed    


    January 2022
  21. ATMAR RL, Lyke KE, Deming ME, Jackson LA, et al
    Homologous and Heterologous Covid-19 Booster Vaccinations.
    N Engl J Med. 2022 Jan 26. doi: 10.1056/NEJMoa2116414.
    PubMed     Abstract available


    December 2021
  22. TURKOVA A, White E, Mujuru HA, Kekitiinwa AR, et al
    Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children.
    N Engl J Med. 2021;385:2531-2543.
    PubMed     Abstract available


  23. COLLIE S, Champion J, Moultrie H, Bekker LG, et al
    Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa.
    N Engl J Med. 2021 Dec 29. doi: 10.1056/NEJMc2119270.
    PubMed    


  24. CATTAMANCHI A, Reza TF, Nalugwa T, Adams K, et al
    Multicomponent Strategy with Decentralized Molecular Testing for Tuberculosis.
    N Engl J Med. 2021;385:2441-2450.
    PubMed     Abstract available


  25. BOR J, Onoya D, Richman B, Mayer KH, et al
    A Failure to Disseminate Transformative Science - HIV Treatment as Prevention, 10 Years On.
    N Engl J Med. 2021;385:2305-2307.
    PubMed    


  26. BRAVO MS
    Emperor of the Empire.
    N Engl J Med. 2021;385:2215-2217.
    PubMed    


    November 2021
  27. DIETZ BW, Winston LG, Koehler JE, Margaretten M, et al
    Copycat.
    N Engl J Med. 2021;385:1797-1802.
    PubMed    


    October 2021
  28. TSENG ZH, Hsue PY, Moffatt E
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV. Reply.
    N Engl J Med. 2021;385:e50.
    PubMed    


  29. OLALLA J, Pombo M
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed    


  30. KLEIN MD, Keen SK, Simpson RJ Jr
    Sudden Cardiac Death and Myocardial Fibrosis in Persons with HIV.
    N Engl J Med. 2021;385:e50.
    PubMed    


  31. CHEMAITELLY H, Tang P, Hasan MR, AlMukdad S, et al
    Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar.
    N Engl J Med. 2021 Oct 6. doi: 10.1056/NEJMoa2114114.
    PubMed     Abstract available


    September 2021
  32. SAAG MS
    HIV Infection - Screening, Diagnosis, and Treatment. Reply.
    N Engl J Med. 2021;385:1344.
    PubMed    


  33. DE SOCIO GV
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;385:1344.
    PubMed    


  34. LEINER S
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;385:1343-1344.
    PubMed    


  35. BAYER R, Oppenheimer GM, Parisi V
    Marking the 40th Anniversary of the AIDS Epidemic - American Physicians Look Back.
    N Engl J Med. 2021;385:1251-1253.
    PubMed    


  36. GOUVEIA-MORAES F, Campos N
    Conjunctival Kaposi's Sarcoma.
    N Engl J Med. 2021;385:e36.
    PubMed    


  37. NEILAN AM, Salvant Valentine S, Knopf AS
    Case 27-2021: A 16-Year-Old Boy Seeking Human Immunodeficiency Virus Prophylaxis.
    N Engl J Med. 2021;385:1034-1041.
    PubMed    


    August 2021
  38. PURUSHOTHAMAN S, Mayakuntla B
    Circinate Syphilitic Lesions.
    N Engl J Med. 2021;385:e26.
    PubMed    


  39. ABDOOL KARIM Q
    Enhancing HIV Prevention with Injectable Preexposure Prophylaxis.
    N Engl J Med. 2021;385:652-653.
    PubMed    


  40. LANDOVITZ RJ, Donnell D, Clement ME, Hanscom B, et al
    Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
    N Engl J Med. 2021;385:595-608.
    PubMed     Abstract available


  41. GOLDSTEIN RH, Mehan WA, Hutchison B, Robbins GK, et al
    Case 24-2021: A 63-Year-Old Woman with Fever, Sore Throat, and Confusion.
    N Engl J Med. 2021;385:641-648.
    PubMed    


  42. COREY L, Beyrer C, Cohen MS, Michael NL, et al
    SARS-CoV-2 Variants in Patients with Immunosuppression.
    N Engl J Med. 2021;385:562-566.
    PubMed    


    July 2021
  43. PATON NI, Musaazi J, Kityo C, Walimbwa S, et al
    Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.
    N Engl J Med. 2021;385:330-341.
    PubMed     Abstract available


    June 2021
  44. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    SARS-CoV-2 Variants and Vaccines.
    N Engl J Med. 2021 Jun 23. doi: 10.1056/NEJMsr2105280.
    PubMed     Abstract available


  45. TSENG ZH, Moffatt E, Kim A, Vittinghoff E, et al
    Sudden Cardiac Death and Myocardial Fibrosis, Determined by Autopsy, in Persons with HIV.
    N Engl J Med. 2021;384:2306-2316.
    PubMed     Abstract available


  46. SAAG MS
    HIV Infection - Screening, Diagnosis, and Treatment.
    N Engl J Med. 2021;384:2131-2143.
    PubMed    


    May 2021
  47. RUBIN EJ, Baden LR, Gray GE, Morrissey S, et al
    Audio Interview: Vaccination and Variants in the U.S. and South Africa.
    N Engl J Med. 2021;384:e85.
    PubMed    


  48. DORMAN SE, Nahid P, Kurbatova EV, Phillips PPJ, et al
    Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.
    N Engl J Med. 2021;384:1705-1718.
    PubMed     Abstract available


  49. SHINDE V, Bhikha S, Hoosain Z, Archary M, et al
    Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 May 5. doi: 10.1056/NEJMoa2103055.
    PubMed     Abstract available


    April 2021
  50. KATZ IT, Weintraub R, Bekker LG, Brandt AM, et al
    From Vaccine Nationalism to Vaccine Equity - Finding a Path Forward.
    N Engl J Med. 2021;384:1281-1283.
    PubMed    


  51. NORASETHASOPON T, Boonyagars L
    Talaromycosis.
    N Engl J Med. 2021;384:1261.
    PubMed    


    March 2021
  52. QUINN SC, Andrasik MP
    Addressing Vaccine Hesitancy in BIPOC Communities - Toward Trustworthiness, Partnership, and Reciprocity.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103104.
    PubMed    


  53. NACHEGA JB, Sam-Agudu NA, Mellors JW, Zumla A, et al
    Scaling Up Covid-19 Vaccination in Africa - Lessons from the HIV Pandemic.
    N Engl J Med. 2021 Mar 31. doi: 10.1056/NEJMp2103313.
    PubMed    


  54. FEINBERG MB
    Uhambo - Twists and Turns on the Journey to an Efficacious HIV-1 Vaccine.
    N Engl J Med. 2021;384:1157-1159.
    PubMed    


  55. GRAY GE, Bekker LG, Laher F, Malahleha M, et al
    Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
    N Engl J Med. 2021;384:1089-1100.
    PubMed     Abstract available


  56. WALKER BD
    The AMP Trials - A Glass Half Full.
    N Engl J Med. 2021;384:1068-1069.
    PubMed    


  57. COREY L, Gilbert PB, Juraska M, Montefiori DC, et al
    Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
    N Engl J Med. 2021;384:1003-1014.
    PubMed     Abstract available


  58. THAMMAVARANUCUPT K, Spanuchart I
    Sulfonamide Crystals.
    N Engl J Med. 2021;384:1053.
    PubMed    


  59. MADHI SA, Baillie V, Cutland CL, Voysey M, et al
    Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.
    N Engl J Med. 2021 Mar 16. doi: 10.1056/NEJMoa2102214.
    PubMed     Abstract available


    December 2020
  60. HELLER HM, Gonzalez RG, Edlow BL, Ard KL, et al
    Case 40-2020: A 24-Year-Old Man with Headache and Covid-19.
    N Engl J Med. 2020;383:2572-2580.
    PubMed    


  61. PAN H, Peto R, Henao-Restrepo AM, Preziosi MP, et al
    Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMoa2023184.
    PubMed     Abstract available


  62. KRAUSE PR, Fleming TR, Longini IM, Peto R, et al
    Placebo-Controlled Trials of Covid-19 Vaccines - Why We Still Need Them.
    N Engl J Med. 2020 Dec 2. doi: 10.1056/NEJMp2033538.
    PubMed    


    November 2020
  63. MITJA O, Corbacho-Monne M, Ubals M, Alemany A, et al
    A Cluster-Randomized Trial of Hydroxychloroquine for Prevention of Covid-19.
    N Engl J Med. 2020 Nov 24. doi: 10.1056/NEJMoa2021801.
    PubMed     Abstract available


    October 2020
  64. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Covid-19 and the President.
    N Engl J Med. 2020;383:e104.
    PubMed    


  65. CELUM C, Barnabas R, Cohen MS, Collier A, et al
    Covid-19, Ebola, and HIV - Leveraging Lessons to Maximize Impact.
    N Engl J Med. 2020 Oct 7. doi: 10.1056/NEJMp2022269.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: